Expression approaches of estrogen receptors (ER), progesterone receptors (PgR), and HER2 receptors, and evaluation of clinical variables, such as nodal involvement, tumor size, histological type, tumor grade, and surgical margins, are widely used to determine treatment and also a prediction of effective breast cancer prognosis [3, 4]. The gene discussed is PGR; the disease is breast cancer.